Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1586/14737159.2015.1025757 http://scihub22266oqcxt.onion/10.1586/14737159.2015.1025757 C4673513!4673513!25774007     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Mol+Diagn 2015 ; 15 (5): 617-29 Nephropedia Template TP {{tp|p=25774007|t=2015. Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?|pdf=|usr=}}{{25774007}} gab.com Text Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary JO: Expert Rev Mol Diagn http://www.kidney.de/pget.php?&tw=1&pmid=25774007 #FOAvip The past decade saw the advent of a number of promising biomarkers to detect pregnancies at risk for preeclampsia (PE), the foremost being those associated with an imbalance of angiogenic factors. In late pregnancy, these are useful for the detection of imminent cases of PE, while earlier they were more predictive for early- than late-onset PE. This suggests that there may be fundamental differences between the underlying pathology of these two PE forms. Therefore, it is possible that such a biological premise may limit the development of biomarkers that will permit the efficacious detection of both early- and late-onset PE via an analysis of first-trimester maternal blood samples. Consequently, a significant increase in our understanding of the underlying pathology of PE, using a variety of approaches ranging from systems biology to animal models, will be necessary in order to overcome this obstacle. Twit Text FOAVip Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary ????Expert Rev Mol Diagn http://www.kidney.de/pget.php?&tw=1&pmid=25774007 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25774007 #FOAvip English Wikipedia <ref>{{Cite pmid|25774007}}</ref> Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary? #MMPMID25774007 Hahn S; Lapaire O; Than NG Expert Rev Mol Diagn 2015[May]; 15 (5): 617-29 PMID25774007show ga The past decade saw the advent of a number of promising biomarkers to detect pregnancies at risk for preeclampsia (PE), the foremost being those associated with an imbalance of angiogenic factors. In late pregnancy, these are useful for the detection of imminent cases of PE, while earlier they were more predictive for early- than late-onset PE. This suggests that there may be fundamental differences between the underlying pathology of these two PE forms. Therefore, it is possible that such a biological premise may limit the development of biomarkers that will permit the efficacious detection of both early- and late-onset PE via an analysis of first-trimester maternal blood samples. Consequently, a significant increase in our understanding of the underlying pathology of PE, using a variety of approaches ranging from systems biology to animal models, will be necessary in order to overcome this obstacle. äBiomarker development for presymptomatic molecular diagnosis of preecl(epmc).pdf DeepDyve Pubget Overpricing